Position in HROW
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$621,598
-$150,446 QoQ
Shares Held
17,629
+11.9% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Atria Investments, Inc holds $19,449,833 across 15 Drug Manufacturers - Specialty & Generic names. HROW ranks #9 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
62,275 | $7,361,527 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
102,225 | $2,446,244 | |
| 3 | VTRS |
Viatris Inc
|
146,223 | $1,975,472 | |
| 4 | HLN |
Haleon plc
|
166,608 | $1,667,746 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
10,939 | $1,441,103 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,952 | $992,514 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
14,395 | $853,191 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
1,132 | $671,253 |
All Filings in HROW
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $621,598 | 17,629 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $772,044 | 15,756 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||